Description
Brinzopt is a sterile ophthalmic suspension containing Brinzolamide 1% (10 mg/mL), a carbonic anhydrase inhibitor that effectively reduces elevated intraocular pressure (IOP) by decreasing aqueous humor production in the eye. Manufactured by Aristopharma Ltd., Brinzopt is indicated for the management of ocular hypertension and open-angle glaucoma, either as monotherapy or as an adjunct to beta-blockers.
.webp)
.jpeg)
.webp)
 4ML.jpg)
.webp)
.jpeg)
 1000 MG.jpg)
Change Language